Global Information
회사소개 | 문의 | 위시리스트

미국, 유럽, 일본의 분자진단 분석장치 및 시약 시장 : 시장 분석, 경쟁기업 정보, 기술 동향, 공급업체의 기회

Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

리서치사 Venture Planning Group
발행일 상품 코드 361365
페이지 정보 영문
가격
US $ 14,500 ₩ 17,165,000 DataPack
US $ 24,500 ₩ 29,003,000 PDF by E-mail (Local License)
US $ 35,000 ₩ 41,433,000 PDF by E-mail (Global License)


미국, 유럽, 일본의 분자진단 분석장치 및 시약 시장 : 시장 분석, 경쟁기업 정보, 기술 동향, 공급업체의 기회 Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
발행일 : 페이지 정보 : 영문

세계의 분자진단(Molecular Diagnostic) 시장을 조사 분석했으며, 미국·유럽·아시아에 초점을 맞추어 비지니스 및 기술 동향, 검사 건수와 매출액 예측, 주요 기업의 시장 점유율, 주요 분석장치의 기능 비교, 기존 기업/신규 기업 개요, 고유의 제품과 사업 기회 등의 정보를 전해드립니다.

제1장 서론

제2장 주요 제품 개발 기회

  • 검사기기
  • 시약 키트와 검사 시스템/패널
  • 컴퓨터, 소프트웨어, 오토메이션
  • 보조제품

제3장 분산형 검사 제품의 설계 기준

제4장 대체적인 시장 침투 전략

  • 자사개발
  • 공동개발
  • 대학과의 제휴
  • 분산형 검사 시장의 유통 전략

제5장 잠재적인 시장 진출 장벽과 리스크

  • 시장 성숙
  • 비용 억제
  • 경쟁
  • 기술적 우위성과 한계
  • 특허권 보호
  • 규제상 제약
  • 분산형 검사 시장이 해결해야 할 과제

제6장 세계 시장과 기술 분석

  • DNA 시퀀싱
  • DNA·RNA 프로브 기술
  • 검출 기술
  • 분자진단 검사 기기 리뷰
  • 바이오칩 : Genosensors, Microarrays, Labs-on-the-Chip
  • 약물유전체학(Pharmacogenomics)
  • 주요 용도
    • 미생물/감염증
    • 암검사
    • 유전병
    • 포렌식 검사
    • 친자확인검사/HLA Typing
    • 기타 응용
  • 경쟁/보완 기술

제7장 세계 시장 개요

  • 비지니스 환경
  • 시장 구조
  • 시장 규모와 성장률

제8장 프랑스의 분자진단 시장

  • 주요 요약
  • 비지니스 환경
  • 시장 구조
  • 시장 규모, 검사 건수와 매출액 예측, 주요 공급업체의 매출액과 시장 점유율

제9장 독일의 분자진단 시장

  • 주요 요약
  • 비지니스 환경
  • 시장 구조
  • 시장 규모, 검사 건수와 매출액 예측, 주요 공급업체의 매출액과 시장 점유율

제10장 이탈리아의 분자진단 시장

  • 주요 요약
  • 비지니스 환경
  • 시장 구조
  • 시장 규모, 검사 건수와 매출액 예측, 주요 공급업체의 매출액과 시장 점유율

제11장 일본의 분자진단 시장

  • 주요 요약
  • 비지니스 환경
  • 시장 구조
  • 시장 규모, 검사 건수와 매출액 예측, 주요 공급업체의 매출액과 시장 점유율

제12장 스페인의 분자진단 시장

  • 주요 요약
  • 비지니스 환경
  • 시장 구조
  • 시장 규모, 검사 건수와 매출액 예측, 주요 공급업체의 매출액과 시장 점유율

제13장 영국의 분자진단 시장

  • 주요 요약
  • 비지니스 환경
  • 시장 구조
  • 시장 규모, 검사 건수와 매출액 예측, 주요 공급업체의 매출액과 시장 점유율

제14장 미국의 분자진단 시장

  • 주요 요약
  • 비지니스 환경
  • 시장 구조
  • 시장 규모, 검사 건수와 매출액 예측, 주요 공급업체의 매출액과 시장 점유율

제15장 경쟁기업 프로파일

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorpCepheid
  • Cepheid
  • Decode Genetics
  • Diadexus
  • Eiken Chemical
  • Elitech Group
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Monogram Biosciences/LabCorp
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio Inc.
  • Tecan Group
  • Thermo Fisher

제16장 부록

  • 분자진단 기술을 개발하고 있는 주요 대학 및 연구기관

도표

LSH 16.07.14

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

This new seven-country study from LeadingMarketResearch.com contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

Highlights

- Business and technological trends in seven major markets:
   France, Germany, Italy, Japan, Spain, UK, and US
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Profiles of market players and start-up firms developing
   innovative technologies and products
- Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Worldwide Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market
  segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Sales and market shares of major suppliers of molecular diagnostic reagent kits and components.

- Five-year test volume and sales forecasts for major applications, including:

- Infectious Diseases        - Forensic Testing
- Cancer                                - Paternity Testing/HLA Typing
- Genetic Diseases             - Others

- Five-year test volume and sales projections for over 30 NAT assays.

- A comprehensive analysis of the sequencing market, by country and laboratory segment,
  including:

- Industrial        - Academic
- Government   - Commercial

- Detailed market segmentation analysis, including review of the market dynamics, trends,
  structure, size, growth and major suppliers, by country.

Product/Technology Review

- Comparison of leading molecular diagnostic analyzers from Abbott, Beckman Coulter, BD,
  Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
  trends in testing automation and over 30 target/signal amplification methods, including:

- PCR     - bDNA
- SDA     - NASBA
- TMA    - SSSR, and others
- LCR

- Worldwide listings of companies, universities and research centers developing new molecular-
   diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, collaborative arrangements and
  new technologies/products in R&D.

- Comprehensive listings of companies developing and marketing molecular diagnostics products,
  by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal
  during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Methodology

This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as VPGMarketResearch’s proprietary data base was conducted.

Contains 1,398 pages and 194 tables

Table of Contents

I. Introduction

II. Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/panels
  • C. Computers, Software and Automation
  • D. Auxiliary Products

III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies For Decentralized Testing Markets

V. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge And Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VI. Worldwide Market and Technology Review

  • A. DNA Sequencing
    • 1. Introduction
    • 2. Sequencing Methods
    • 3. Autoradiography
    • 4. The Human Genome Project
    • 5. Sequencing Automation
    • 6. Image Scanners
    • 7. Fluorescent Detection
    • 8. Gene Profiling
    • 9. Gene Expression
    • 10. Polymorphism Screening
    • 11. Protein Interaction Networks
  • B. DNA and RNA Probe Technologies
    • 1. Basic Principles
    • 2. Probe Preparation
    • 3. The DNA Probe Test
    • 4. Test Formats
    • 5. Labeling Techniques
    • 6. Amplification Methods
  • C. Detection Technologies
    • 1. Radioactive Methods
      • a. Overview
      • b. Major Isotopes
        • P-32
        • S-35
        • H-3
        • I-125
    • 2. Non-Isotopic Methods
      • a. Enzymatic Labels
      • b. Chemical Labeling
        • Indirect Chemical Labeling
        • Direct Chemical Labeling
      • c. Fluorescence
      • d. Chemiluminescence
      • e. Electrical Conductivity
  • D. Molecular Diagnostic Instrumentation Review
    • 1. Abbott LCx
    • 2. Beckman Coulter/Biomek FK
    • 3. BD Viper System with XTR Technology
    • 4. BD Innova
    • 5. Becton Dickinson SDA
    • 6. bioMerieux NucliSENS easyMAG
    • 7. bioMerieux NucliSENS easyQ and MiniMAG
    • 8. Bio-Rad GeneScope
    • 9. Cepheid GeneXpert
    • 10. Curetis Unyvero
    • 11. GenMark Dx eSensor XT-8
    • 12. Hologic/Gen-Probe Panther
    • 13. Hologic/Gen-Probe Tigris/DTS
    • 14. HTG Molecular Edge
    • 15. Life Technologies QuantStudio Dx
    • 16. Qiagen QIAsymphony RGQ
    • 17. Roche Cobas Amplicor
    • 18. Roche Cobas TaqMan 48
    • 19. Roche Cobas TaqMan
    • 20. Roche Cobas TaqMan AmpliPrep
    • 21. Roche LighCycler 480
    • 22. Roche Cobas 4800
    • 23. Roche Cobas s 201
    • 24. Siemens Versant
    • 25. Tecan LS Series
  • E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
    • Liquid Transportation and Mixing
    • Separation
    • Reaction
    • Detection
  • F. Pharmacogenomics
  • G. Major Applications
    • 1. Microbiology/Infectious Diseases
      • a. Overview
      • b. Major Infectious Diseases
        • AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
          • Adenovirus
          • Aeromonas
          • Anthrax/Bacillus Anthracis
          • Arboviruses
          • Babesiosis
          • Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
          • Blastocystis Hominis
          • Brucella
          • Campylobacter
          • Candida
          • Chagas Disease
          • Chancroid
          • Chlamydia
          • Clostridium Difficile
          • Coronaviruses
          • Coxsackieviruses
          • Creutzfeldt-Jakob's Disease
          • Cryptosporidium Parvum
          • Cyclospora Cayetanensis
          • Cytomegalovirus
          • Ebola Virus
          • E. Coli
          • EchoVirus
          • Encephalitis
          • Enteroviruses
          • Epstein-Barr Virus
          • Giardia Lamblia
          • Gonorrhea
          • Granuloma Inguinale
          • Hantavirus
          • Helicobacter Pylori
        • Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
          • Herpes Simplex Virus
          • Human Herpes Virus-6 (HHV-6)
          • Influenza Viruses
          • Legionella
          • Lyme Disease
          • Lymphogranuloma Venereum (LGV)
          • Malaria
          • Measles (Rubeola)
          • Meningitis
          • Microsporidium
          • Mononucleosis
          • Mumps
          • Mycoplasma
          • Papillomaviruses
          • Parvovirus B19
          • Pneumonia
          • Polyomaviruses
          • Pseudomonas Aeruginosa
          • Rabies
          • Respiratory Syncytial Virus (RSV)
          • Rhinoviruses
          • Rotavirus
          • Rubella
          • Salmonellosis
          • Septicemia
          • Shigellosis
          • Staphylococcus Aureus
          • Streptococci
          • Syphilis
          • Toxoplasmosis
          • Trichomonas Vaginalis
          • Tuberculosis
          • Vibrio
          • West Nile Virus
          • Yersinia
    • 2. Cancer Testing
      • a. Overview
      • b. Major Cancer Types
        • Prostate
        • Lung
        • Colon and Rectum
        • Breast
        • Skin
        • Uterine
        • Leukemia
        • Oral
      • c. Oncogenes
        • Abl/abl-bcr
        • AIB1
        • BCL-2
        • BRCA1
        • CD44
        • C-fos
        • C-myb
        • C-myc
        • CYP17
        • Erb-B
        • HPC1
        • N-myc
        • P40
        • P51
        • P53
        • PIK3CA
        • PTI-1
        • Ras
        • Reg
        • Sis
        • Src
    • 3. Genetic Diseases
      • a. Overview
      • b. Nucleic Acid Amplification
      • c. Chromosome Imaging
      • d. Genomics Technologies
      • e. Proteomics Technologies
      • f. Current Pharmacogenomic Tests
      • g. Future Pharmacogenomic Testing
      • h. Major Diseases
        • Achondroplasia
        • Autosomal Dominant Polycystic Kidney Disease
          • Cancer
          • Cosmetogenomics
          • Cystic Fibrosis
          • Down's Syndrome
          • Duchenne and Becker Muscular Dystrophy
          • Factor V (Leiden)
          • Factor IX Deficiency
          • Fragile X Syndrome
          • Heart Disease
          • Hemochomatosis
          • Hemophilia
          • Huntington's Disease
          • Maternal-Fetal Incompatibility
          • Multiple Endocrine Neoplasia
          • Phenylketonuria (PKU)
          • Polycystic Kidney Disease (PKD)
          • Prenatal Screening
          • Retinitis Pigmentosa
          • Retinoblastoma
          • Sickle Cell Anemia
          • Spinal Muscular Atrophy
          • Vitamin B12 Metabolism
      • i. Social Issues and Concerns
    • 4. Forensic Testing
      • a. Overview
      • b. Multilocus and Single Locus Probes
        • Multilocus Probes
        • Single Locus Probes
        • PCR and RFLP
      • c. The FBI
      • d. DNA Profile Data Banks
        • U.S.A.
        • U.K.
      • e. Judicial Implementation
      • f. Major Crime Categories
      • g. Factors Contributing to the DNA Probe Market Expansion
        • Technology Availability
        • Use of Hair as Evidence
      • h. Wildlife Forensics
    • 5. Paternity Testing/HLA Typing
    • 6. Other Applications
      • a. Disease Susceptibility Testing
      • b. Cardiovascular Diseases
      • c. Diabetes
      • d. Alzheimer's Disease
      • e. Periodontal Disease
      • f. Plasma Purification
      • g. Organ Transplantation
      • h. Water Contamination
      • i. Other
  • H. Competing/complementing
    • 1. Monoclonal Antibodies/Immunoassays
    • 2. RNA Probes
    • 3. Two-Dimensional Electrophoresis
    • 4. Flow Cytometry

VII. Worldwide Market Overview

  • 1. Business Environment
  • 2. Market Structure
  • 3. Market Size and Growth

VIII. France Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

IX. Germany Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

X. Italy Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XI. Japan Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XII. Spain Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XIII. U.K. Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XIV. U.S.A. Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XV. Competitive Assessments

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorpCepheid
  • Cepheid
  • Decode Genetics
  • Diadexus
  • Eiken
  • Elitech Group
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Monogram Biosciences/LabCorp
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group
  • Thermo Fisher

XVI. Appendix: Major Universities and Research Centers Developing Molecular Diagnostic Technologies

List of Tables

  • Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests Oncogenes Potential Application in Cancer Diagnosis
  • Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
  • Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
  • Worldwide, Laboratories Performing DNA Sequencing by Country
  • Worldwide, Molecular Diagnostics Market Potential Laboratory Universe by Country
  • Worldwide, Molecular Diagnostic Test Volume Forecast by Country
  • Worldwide, Molecular Diagnostics Market Forecast by Country
  • France Molecular Diagnostics Test Volume And Sales By Major Application
  • France Laboratories Performing DNA Sequencing By Market Segment
  • France Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • France Molecular Diagnostics Test Volume By Major Application
  • France Major Infectious Disease Test Volume by Assay
  • France Major Infectious Disease Test Volume by Method
  • France Molecular Diagnostics Market By Major Application
  • France Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
  • France Major Infectious Disease Diagnostics Market by Assay
  • France AIDS Testing Market Estimated Sales by Major Supplier
  • France Adenovirus Testing Market Estimated Sales by Major Supplier
  • France Chlamydia Testing Market Estimated Sales by Major Supplier
  • France CMV Testing Market Estimated Sales by Major Supplier
  • France Gonorrhea Testing Market Estimated Sales by Major Supplier
  • France Hepatitis Testing Market Estimated Sales by Major Supplier
  • France Hepatitis C Testing Market Estimated Sales by Major Supplier
  • France HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
  • France Herpes Testing Market Estimated Sales by Major Supplier
  • France Influenza Testing Market Estimated Sales by Major Supplier
  • France Meningitis Testing Market Estimated Sales by Major Supplier
  • France Mycoplasma Testing Market Estimated Sales by Major Supplier
  • France RSV Testing Market Estimated Sales by Major Supplier
  • France Shigella Testing Market
  • Estimated Sales by Major Supplier
  • Germany Molecular Diagnostics Test Volume And Sales By Major Application
  • Germany Laboratories Performing DNA Sequencing By Market Segment
  • Germany Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Germany Molecular Diagnostics Test Volume By Major Application
  • Germany Major Infectious Disease Test Volume by Assay
  • Germany Major Infectious Disease Test Volume by Method
  • Germany Molecular Diagnostics Market By Major Application
  • Germany Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
  • Germany Major Infectious Disease Diagnostics Market by Assay
  • Germany AIDS Testing Market Estimated Sales by Major Supplier
  • Germany CMV Testing Market Estimated Sales by Major Supplier
  • Germany EBV Testing Market Estimated Sales by Major Supplier
  • Germany Gonorrhea Testing Market Estimated Sales by Major Supplier
  • Germany Hepatitis Testing Market Estimated Sales by Major Supplier
  • Germany Hepatitis C Testing Market Estimated Sales by Major Supplier
  • Germany HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
  • Germany Herpes Testing Market Estimated Sales by Major Supplier
  • Germany Influenza Testing Market Estimated Sales by Major Supplier
  • Germany Meningitis Testing Market Estimated Sales by Major Supplier
  • Germany Mycoplasma Testing Market Estimated Sales by Major Supplier
  • Germany Pneumonia Testing Market Estimated Sales by Major Supplier
  • Germany RSV Testing Market Estimated Sales by Major Supplier
  • Germany Rotavirus Testing Market
  • Estimated Sales by Major Supplier
  • Italy Molecular Diagnostics Test Volume And Sales By Major Application
  • Italy Laboratories Performing DNA Sequencing By Market Segment
  • Italy Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Italy Molecular Diagnostics Test Volume By Major Application
  • Italy Major Infectious Disease Test Volume by Assay
  • Italy Major Infectious Disease Test Volume by Method
  • Italy Molecular Diagnostics Market By Major Application
  • Italy Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
  • Italy Major Infectious Disease Diagnostics Market by Assay
  • Italy AIDS Testing Market Estimated Sales by Major Supplier
  • Italy CMV Testing Market Estimated Sales by Major Supplier
  • Italy Gonorrhea Testing Market Estimated Sales by Major Supplier
  • Italy Hepatitis Testing Market Estimated Sales by Major Supplier
  • Italy Hepatitis C Testing Market Estimated Sales by Major Supplier
  • Italy HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
  • Italy Herpes Testing Market Estimated Sales by Major Supplier
  • Italy Influenza Testing Market Estimated Sales by Major Supplier
  • Italy Meningitis Testing Market Estimated Sales by Major Supplier
  • Italy Mycoplasma Testing Market Estimated Sales by Major Supplier
  • Italy RSV Testing Market
  • Estimated Sales by Major Supplier
  • Japan Molecular Diagnostics Test Volume And Sales By Major Application
  • Japan Laboratories Performing DNA Sequencing By Market Segment
  • Japan Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Japan Molecular Diagnostics Test Volume By Major Application
  • Japan Major Infectious Disease Test Volume by Assay
  • Japan Major Infectious Disease Test Volume by Method
  • Japan Molecular Diagnostics Market By Major Application
  • Japan Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
  • Japan Major Infectious Disease Diagnostics Market by Assay
  • Japan AIDS Testing Market Estimated Sales by Major Supplier
  • Japan Chlamydia Testing Market Estimated Sales by Major Supplier
  • Japan CMV Testing Market Estimated Sales by Major Supplier
  • Japan Gonorrhea Testing Market Estimated Sales by Major Supplier
  • Japan Hepatitis Testing Market Estimated Sales by Major Supplier
  • Japan Hepatitis C Testing Market Estimated Sales by Major Supplier
  • Japan Herpes Testing Market Estimated Sales by Major Supplier
  • Japan Meningitis Testing Market Estimated Sales by Major Supplier
  • Japan Mycoplasma Testing Market Estimated Sales by Major Supplier
  • Japan Pneumonia Testing Market Estimated Sales by Major Supplier
  • Japan Shigella Testing Market
  • Estimated Sales by Major Supplier
  • Spain Molecular Diagnostics Test Volume And Sales By Major Application
  • Spain Laboratories Performing DNA Sequencing By Market Segment
  • Spain Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Spain Molecular Diagnostics Test Volume By Major Application
  • Spain Major Infectious Disease Test Volume by Assay
  • Spain Major Infectious Disease Test Volume by Method
  • Spain Molecular Diagnostics Market By Major Application
  • Spain Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
  • Spain Major Infectious Disease Diagnostics Market by Assay
  • Spain AIDS Testing Market Estimated Sales by Major Supplier
  • Spain Chlamydia Testing Market Estimated Sales by Major Supplier
  • Spain CMV Testing Market Estimated Sales by Major Supplier
  • Spain Gonorrhea Testing Market Estimated Sales by Major Supplier
  • Spain Hepatitis Testing Market Estimated Sales by Major Supplier
  • Spain Hepatitis C Testing Market Estimated Sales by Major Supplier
  • Spain HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
  • Spain Herpes Testing Market Estimated Sales by Major Supplier
  • Spain Influenza Testing Market Estimated Sales by Major Supplier
  • Spain Meningitis Testing Market Estimated Sales by Major Supplier
  • Spain Mycoplasma Testing Market
  • Estimated Sales by Major Supplier
  • U.K. Molecular Diagnostics Test Volume And Sales By Major Application
  • U.K. Laboratories Performing DNA Sequencing By Market Segment
  • U.K. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • U.K. Molecular Diagnostics Test Volume By Major Application
  • U.K. Major Infectious Disease Test Volume by Assay
  • U.K. Major Infectious Disease Test Volume by Method
  • U.K. Molecular Diagnostics Market By Major Application
  • U.K. Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
  • U.K. Major Infectious Disease Diagnostics Market by Assay
  • U.K. AIDS Testing Market Estimated Sales by Major Supplier
  • U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier
  • U.K. Hepatitis Testing Market Estimated Sales by Major Supplier
  • U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier
  • U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
  • U.K. Influenza Testing Market Estimated Sales by Major Supplier
  • U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier
  • U.K. Pneumonia Testing Market Estimated Sales by Major Supplier
  • U.K. Shigella Testing Market
  • Estimated Sales by Major Supplier
  • U.S.A. Molecular Diagnostics Test Volume And Sales By Major Application
  • U.S.A. Laboratories Performing DNA Sequencing By Market Segment
  • U.S.A. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • U.S.A. Molecular Diagnostics Test Volume by Major Application
  • U.S.A. Major Infectious Disease Test Volume by Assay
  • U.S.A. Major Infectious Disease Test Volume by Method
  • U.S.A. Molecular Diagnostics Market By Major Application
  • U.S.A. Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
  • U.S.A. Major Infectious Disease Diagnostics Market by Assay
  • U.S.A. AIDS Testing Market Estimated Sales by Major Supplier
  • U.S.A. Adenovirus Testing Market Estimated Sales by Major Supplier
  • U.S.A. Chlamydia Testing Market Estimated Sales by Major Supplier
  • U.S.A. CMV Testing Market Estimated Sales by Major Supplier
  • U.S.A. Echovirus Testing Market Estimated Sales by Major Supplier
  • U.S.A. Enterovirus Testing Market Estimated Sales by Major Supplier
  • U.S.A. EBV Testing Market Estimated Sales by Major Supplier
  • U.S.A. Gonorrhea Testing Market Estimated Sales by Major Supplier
  • U.S.A. Hepatitis Testing Market Estimated Sales by Major Supplier
  • U.S.A. Hepatitis C Testing Market Estimated Sales by Major Supplier
  • U.S.A. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
  • U.S.A. Herpes Testing Market Estimated Sales by Major Supplier
  • U.S.A. Influenza Testing Market Estimated Sales by Major Supplier
  • U.S.A. Meningitis Testing Market Estimated Sales by Major Supplier
  • U.S.A. Mycoplasma Testing Market Estimated Sales by Major Supplier
  • U.S.A. Pneumonia Testing Market Estimated Sales by Major Supplier
  • U.S.A. Rabies Testing Market Estimated Sales by Major Supplier
  • U.S.A. RSV Testing Market Estimated Sales by Major Supplier
  • U.S.A. Salmonella Testing Market Estimated Sales by Major Supplier
  • U.S.A. Shigella Testing Market Estimated Sales by Major Supplier
  • U.S.A. West Nile Virus Nat Market Reagent Sales by Major Supplier
Back to Top
전화 문의
F A Q